These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer. Liu CY, Wu CY, Lin JT, Lee YC, Yen AM, Chen TH. J Med Screen; 2006; 13 Suppl 1():S2-5. PubMed ID: 17227633 [Abstract] [Full Text] [Related]
26. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas. Yang MH, Son HJ, Lee JH, Kim MH, Kim JY, Kim YH, Chang DK, Rhee PL, Kim JJ, Rhee JC. Gastrointest Endosc; 2010 Apr; 71(4):774-81. PubMed ID: 20363417 [Abstract] [Full Text] [Related]
29. [Associated risk factors in patients with gastric intestinal metaplasia with mild gastroduodenal disease. Is it always related to Helicobacter pylori infection?]. Chacaltana Mendoza A, Soriano Álvarez C, Frisancho Velarde O. Rev Gastroenterol Peru; 2012 Apr; 32(1):50-7. PubMed ID: 22476178 [Abstract] [Full Text] [Related]
30. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Int J Cancer; 2014 Mar 15; 134(6):1445-57. PubMed ID: 24009139 [Abstract] [Full Text] [Related]
32. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D. Int J Cancer; 2003 Mar 01; 103(6):815-21. PubMed ID: 12516104 [Abstract] [Full Text] [Related]
33. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T. Gastrointest Endosc; 2012 Jan 01; 75(1):39-46. PubMed ID: 22018552 [Abstract] [Full Text] [Related]
35. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Hosokawa O, Miyanaga T, Kaizaki Y, Hattori M, Dohden K, Ohta K, Itou Y, Aoyagi H. Scand J Gastroenterol; 2008 Jan 01; 43(9):1112-5. PubMed ID: 18609154 [Abstract] [Full Text] [Related]
38. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y. Am J Gastroenterol; 2005 May 01; 100(5):1037-42. PubMed ID: 15842576 [Abstract] [Full Text] [Related]
40. Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm. Boda T, Ito M, Yoshihara M, Kitamura Y, Matsuo T, Oka S, Tanaka S, Chayama K. Helicobacter; 2014 Feb 01; 19(1):1-8. PubMed ID: 24215601 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]